Literature DB >> 18832028

Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis.

Karsten H Weylandt1, Anja Nadolny, Lena Kahlke, Thomas Köhnke, Christoph Schmöcker, Jingdong Wang, Gregory Y Lauwers, Jonathan N Glickman, Jing X Kang.   

Abstract

Pancreatitis is a severe debilitating disease with high morbidity and mortality. Treatment is mostly supportive, and until now there are no clinically useful strategies for anti-inflammatory therapy. Although omega-3 polyunsaturated fatty acids (n-3 PUFA) are known to have anti-inflammatory effects, the utility of these fatty acids in the alleviation of pancreatitis remained to be investigated. The aim of this study was to examine the effect of n-3 PUFA on both acute and chronic pancreatitis in a well-controlled experimental system. We used the fat-1 transgenic mouse model, characterized by endogenously increased tissue levels of n-3 PUFA, and their wild-type littermates to examine the effect of n-3 PUFA on both acute and chronic cerulein-induced pancreatitis. Disease activity and inflammatory status were assessed by both histology and molecular methods. In acute pancreatitis, fat-1 mice showed a trend towards decreased necrosis and significantly reduced levels of plasma IL-6 levels as well as reduced neutrophil infiltration in the lung. In chronic pancreatitis there was less pancreatic fibrosis and collagen content accompanied by decreased pancreatic stellate cell activation in the fat-1 animals with increased n-3 PUFA tissue levels as compared to wild-type littermates with high levels of omega-6 (n-6) PUFA in their tissues. Our data provide evidence for a reduction of systemic inflammation in acute pancreatitis and of tissue fibrosis in chronic pancreatitis by increasing the tissue content of omega-3 polyunsaturated fatty acids. These results suggest a beneficial potential for n-3 PUFA supplementation in acute and particularly chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832028      PMCID: PMC2614880          DOI: 10.1016/j.bbadis.2008.08.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

Authors:  S Endres; R Ghorbani; V E Kelley; K Georgilis; G Lonnemann; J W van der Meer; J G Cannon; T S Rogers; M S Klempner; P C Weber
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

2.  Cyclooxygenase-2 plays a central role in the genesis of pancreatitis and associated lung injury.

Authors:  Gavin O'Brien; Conor J Shields; Desmond C Winter; John P Dillon; William O Kirwan; H Paul Redmond
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-02

3.  Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice.

Authors:  David J van Westerloo; Sandrine Florquin; Anita M de Boer; Joost Daalhuisen; Alex F de Vos; Marco J Bruno; Tom van der Poll
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

4.  Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.

Authors:  Dilprit Bagga; Ling Wang; Robin Farias-Eisner; John A Glaspy; Srinivasa T Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

5.  Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids.

Authors:  Jing X Kang; Jingdong Wang; Lin Wu; Zhao B Kang
Journal:  Nature       Date:  2004-02-05       Impact factor: 49.962

6.  Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study.

Authors:  Xinying Wang; Weiqin Li; Ning Li; Jieshou Li
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 May-Jun       Impact factor: 4.016

7.  Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.

Authors:  Peiying Yang; Diana Chan; Edward Felix; Carrie Cartwright; David G Menter; Timothy Madden; Russell D Klein; Susan M Fischer; Robert A Newman
Journal:  J Lipid Res       Date:  2004-03-01       Impact factor: 5.922

8.  COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis.

Authors:  Michele I Slogoff; Richard T Ethridge; Srinivasan Rajaraman; B Mark Evers
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

9.  Troglitazone inhibits the progression of chronic pancreatitis and the profibrogenic activity of pancreatic stellate cells via a PPARgamma-independent mechanism.

Authors:  Kyoko Shimizu; Keiko Shiratori; Makio Kobayashi; Hitoshi Kawamata
Journal:  Pancreas       Date:  2004-07       Impact factor: 3.327

10.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.

Authors:  Makoto Arita; Francesca Bianchini; Julio Aliberti; Alan Sher; Nan Chiang; Song Hong; Rong Yang; Nicos A Petasis; Charles N Serhan
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  26 in total

1.  Potential influence of intravenous lipids on the outcomes of acute pancreatitis.

Authors:  Krutika S Patel; Pawan Noel; Vijay P Singh
Journal:  Nutr Clin Pract       Date:  2014-03-31       Impact factor: 3.080

2.  The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding.

Authors:  Sarah K Orr; Jasmin Y M Tong; Jing X Kang; David W L Ma; Richard P Bazinet
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

3.  Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model: Omega-3 fatty acids prevent liver neoplasia.

Authors:  J Griffitts; D Saunders; Y A Tesiram; G E Reid; A Salih; S Liu; T A Lydic; J V Busik; J X Kang; R A Towner
Journal:  Biochim Biophys Acta       Date:  2010-07-08

4.  Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers.

Authors:  Alison H Keenan; Theresa L Pedersen; Kristi Fillaus; Mark K Larson; Gregory C Shearer; John W Newman
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

5.  Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses.

Authors:  Sueleyman Bilal; Oliver Haworth; Lijun Wu; Karsten H Weylandt; Bruce D Levy; Jing X Kang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

6.  Acute pancreatitis in obesity: adipokines and dietary fish oil.

Authors:  Hayder H Al-Azzawi; Terence E Wade; Deborah A Swartz-Basile; Sue Wang; Henry A Pitt; Nicholas J Zyromski
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

7.  Identification and quantitation of fatty acid double bond positional isomers: a shotgun lipidomics approach using charge-switch derivatization.

Authors:  Kui Yang; Beverly Gibson Dilthey; Richard W Gross
Journal:  Anal Chem       Date:  2013-09-24       Impact factor: 6.986

8.  Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease.

Authors:  Melanie Bousquet; Karl Gue; Vincent Emond; Pierre Julien; Jing X Kang; Francesca Cicchetti; Frederic Calon
Journal:  J Lipid Res       Date:  2010-11-29       Impact factor: 5.922

9.  The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet.

Authors:  Mizanur Rahman; Ganesh V Halade; Arunabh Bhattacharya; Gabriel Fernandes
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition.

Authors:  Jérôme Bellenger; Sandrine Bellenger; Amandine Bataille; Karen A Massey; Anna Nicolaou; Mickaël Rialland; Christian Tessier; Jing X Kang; Michel Narce
Journal:  Diabetes       Date:  2011-02-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.